SCHEMBL25400330

SCHEMBL25400330

COC(=O)C1(Cc2ccccc2)CC(CNC(=O)c2ccnc(Cl)c2)=NO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ KDM5B Q9UGL1 2/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ SLC8A1 P32418 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.36
▸ CTNNB1 P35222 1/20 0.36
▸ TCF7L2 Q9NQB0 1/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25397863 0.86 CHRM1 (0.41) SMN1; SMN2LMNAL3MBTL1ALDH1A1NPC1
SCHEMBL25401868 0.86 TMEM97 (0.40) SMN1; SMN2LMNAHTTL3MBTL1ALDH1A1
SCHEMBL25401149 0.85 NPC1 (0.47) SMN1; SMN2HTTMMP13L3MBTL1ALDH1A1
SCHEMBL25398162 0.84 AURKA (0.46) SMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL25399661 0.84 LMNA (0.37) SMN1; SMN2LMNAHTTL3MBTL1ALDH1A1
SCHEMBL25399804 0.84 HPGDS (0.41) KDM5B
SCHEMBL25396773 0.83 MMP13 (0.51) SMN1; SMN2LMNAMMP13ALDH1A1NPC1
SCHEMBL25397201 0.83 SMN1; SMN2 (0.47) SMN1; SMN2LMNAHTTMMP13NPC1
SCHEMBL29846777 0.82 SCN5A (0.41) SMN1; SMN2LMNAHTTL3MBTL1ALDH1A1
SCHEMBL25397713 0.82 NPC1 (0.49) SMN1; SMN2HTTL3MBTL1ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 — — US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 — — US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 SMN1; SMN2 777/4885LMNA 151/4885HTT 1191/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 SMN1; SMN2 213/4885LMNA 1548/4885HTT 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback